Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplantation in Spinal Cord Injury

Francesca Merighi; Sara De Vincentiis; Marco Onorati; Vittoria Raffa

doi:10.3791/66704

Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplan...

JoVE Journal
Neuroscience

This content is Free Access.

JoVE Journal Neuroscience

Long-Term Mouse Spinal Cord Organotypic Slice Culture as a Platform for Validating Cell Transplantation in Spinal Cord Injury

Full Text

2,347 Views

07:37 min

April 12, 2024

DOI: 10.3791/66704-v

Francesca Merighi¹, Sara De Vincentiis¹, Marco Onorati¹, Vittoria Raffa¹

¹Department of Biology,University of Pisa

Overview

This study introduces a reproducible method for generating and maintaining long-term spinal cord organotypic slices transplanted with neural stem cells. The model serves as an ex vivo platform for evaluating the efficacy of cellular replacement therapies aimed at spinal cord injury.

Key Study Components

Area of Science

Neuroscience
Regenerative medicine
Cellular therapies

Background

Addressing spinal cord injuries remains a significant challenge in neuroscience.
Current organotypic models have limited culture times, affecting their viability for research.
Previous studies showed suboptimal conditions for neural stem cell engraftment and maturation.
Improving cell replacement therapies requires better understanding of cell behavior post-transplantation.

Purpose of Study

To validate a long-term ex vivo spinal cord organotypic model for testing cellular replacement therapies.
To enhance survival, integration, and maturation of engrafted neural stem cells.
To offer a platform that reduces the need for in vivo studies in understanding cell therapies.

Methods Used

The study employed organotypic spinal cord slices as its main platform.
Neural stem cells were used as the key biological model.
Methods outlined are intended to support long-term culture of the organotypic slices.
The protocol aims to be simple, fast, and cost-effective, facilitating proof of concept studies.

Main Results

The model demonstrated improved survival and maturation rates of the grafted neural stem cells.
Integration of the transplanted cells into existing circuits was validated.
Findings suggest that the new method effectively addresses previous limitations in organotypic cultures.
These results support the potential for optimized transplantation strategies for spinal cord injuries.

Conclusions

This study presents a valuable tool for researchers developing cellular therapies for spinal cord injury.
The long-term organotypic model enhances understanding of cell behavior and therapeutic efficacy.
It may lead to better-informed strategies that reduce the need for animal testing in therapeutic research.

Frequently Asked Questions

What are the advantages of this organotypic model?

This model allows for long-term maintenance of spinal cord tissue while facilitating the study of cellular therapies, which enhances data reliability and reduces animal use.

How is the spinal cord organotypic model maintained?

The model is cultured under conditions that support the growth and maturation of neural stem cells, extending viable study periods beyond previous limitations.

What types of data are generated using this model?

Researchers can assess cell survival, integration into host circuits, and differentiation outcomes over an extended culture time.

How can this method be applied in other research areas?

The protocol can be adapted for studies involving various cellular interventions and injury models beyond spinal cord research.

Are there any limitations to this method?

While promising, the method requires further validation to ensure its applicability across different types of spinal cord injuries and therapies.

In this paper, we provide a reproducible method to generate and maintain long-term spinal cord organotypic slices transplanted with neural stem cells as an ex vivo model for testing cellular replacement therapies.

We are interested in developing a promising regenerative approach to address spinal cord injuries. In this paper, we validate spinal cord organotypic model for testing cellular replacement therapies in spinal cord research. So far, spinal cord organotypic models are maintained in culture for two or three weeks in vitro.

And subculture media are suboptimal for neural stem cell engraftment, differentiation, and maturation. Cell replacement therapies still require the improvement to announce the ability of the grafted cells to reconstitute the lost circuits. Through this protocol, we provide a novel, long-term ex vivo platform to tackle cell transplant related issue like survival, integration, and maturation rate of the engrafted neural stem cells.

This platform will be helpful for researchers to find the best strategy for cell transplantation, reducing the number of animals required for in vivo validation. Our protocol is simple, fast, and cost-effective to perform proof of concept and optimization studies.